An In-depth Look at the Cost and Value of the Sensor Medica Freemed Platform for Podiatrists

When considering investing in a gait analysis platform like Sensor Medica's Freemed, it's crucial to balance the cost against the potential value it can bring to your podiatry practice.

In this blog, we'll delve into these two aspects in detail to assist you in making an informed decision.

Section 1: The Cost of the Freemed Platform

The Freemed platform is a sophisticated piece of technology, and as such, it comes with a substantial initial investment. This cost includes the platform itself, as well as any necessary training for your staff to use it effectively. However, it's important to view this cost not merely as an expense but as an investment in the future of your podiatry practice.

Section 2: The Value of Advanced Gait Analysis

Advanced gait analysis is increasingly becoming a standard of care in podiatry, and the Freemed platform excels in this area. It provides detailed, objective data about a patient's walking pattern, enhancing your diagnostic capabilities and allowing you to develop more effective treatment plans.

Higher patient satisfaction, improved treatment outcomes, and a stronger reputation can all stem from the use of advanced gait analysis in your practice. This can lead to an increase in patient referrals, and consequently, your practice's revenue over the long term.

Section 3: The Value of Custom Orthotics Creation

The Freemed platform also offers the capability to create custom orthotics, an increasingly in-demand service in podiatry. Custom orthotics can provide significant relief for patients with various foot conditions, and offering this service can set your practice apart from others.

The potential revenue from custom orthotics creation is substantial. With margins of around £300 per pair when sold at the UK average price of £400, this service can be a significant revenue driver for your practice.

Section 4: Cost of Missed Opportunity

In the rapidly evolving field of podiatry, staying on the cutting edge is crucial. As more practices begin to offer advanced gait analysis and custom orthotics, not investing in the Freemed platform could mean missing out on a significant growth opportunity.

The inability to offer these services could result in lost patients to practices that do, translating into a significant loss of potential revenue. In this light, the cost of the Freemed platform can be viewed not just as an investment but also as a safeguard against the cost of missed opportunities.

Section 5: Long-Term Financial Implications

While the initial investment in the Freemed platform is significant, its long-term financial benefits should also be considered. The enhanced diagnostic and treatment capabilities, the additional revenue from custom orthotics, and the prevention of missed opportunities can all lead to a significant increase in your practice's revenue over time.

The platform is designed to be durable and long-lasting, minimizing ongoing costs such as maintenance and replacement. This makes the Freemed platform not just a short-term expenditure but a long-term investment that can provide a return for many years to come.

Section 6: Making the Decision

Investing in a gait analysis platform like Freemed is a major decision. It requires weighing the upfront cost against the value it can bring to your podiatry practice. However, when the advanced capabilities of the platform, the potential for increased revenue, and the cost of missed opportunities are taken into account, the benefits of the Freemed platform become clear.

Conclusion: Investing in the Sensor Medica Freemed platform is a strategic decision that can bring significant value to your podiatry practice. It's a tool that can enhance your patient care, boost your reputation, and increase your revenue, making it a worthwhile investment. Don't let the cost deter you from exploring the benefits it can bring. Embrace the opportunity and stay ahead in the fast-paced field of podiatry.